This inventor holds 2 USPTO granted patents. Top assignee: Development Center for Biotechnology. Active years: 1996-1998.
Company Filing History:
Years Active: 1996-1998
Title: Innovations of Feng-Wen Yeng
Introduction
Feng-Wen Yeng is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of novel compounds and methods for resolving racemic compounds. With a total of 2 patents to his name, Yeng continues to push the boundaries of innovation in his field.
Latest Patents
Yeng's latest patents include "Antiatherosclerosis agents for lipid-lowering and antiperoxidative," which relates to novel compounds designed to combat atherosclerosis. The invention focuses on compounds of formula (I) wherein R₁ represents hydrogen, hydroxy, or alkoxy. Another significant patent is "Method for resolving racemic compounds," which outlines a method for resolving racemic dimethyl-4,4'-dimethoxy-5,6,5',6'-di(methylenedioxy)biphenyl-2,2'-dicarboxylate (DDB). This method utilizes a chiral α-alkyl benzyl alcohol as the resolving agent, leading to the formation of two chiral isomers through hydrolysis and subsequent reactions.
Career Highlights
Feng-Wen Yeng is associated with the Development Center for Biotechnology, where he applies his expertise in biotechnology to develop innovative solutions. His work has garnered attention for its potential applications in health and medicine.
Collaborations
Yeng collaborates with esteemed colleagues, including Chia-Lin J Wang and Jaw-Yuh Chiu, who contribute to his research endeavors. Their combined efforts enhance the scope and impact of their innovations.
Conclusion
Feng-Wen Yeng's contributions to biotechnology through his patents and collaborations highlight his role as a key innovator in the field. His work continues to inspire advancements that may lead to significant improvements in health and medicine.